Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
NEUROLOGY	O
Allergies:	O
Lisinopril	O
Attending:	O
___.	O
Chief	O
Complaint:	O
confusion	B-Delirium
and	O
ataxia	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
none	O
History	O
of	O
Present	O
Illness:	O
Ms	O
___	O
is	O
a	O
___	O
yo	O
right	O
handed	O
woman	O
with	O
a	O
history	O
of	O
HTN,	O
diabetes,	O
paroxysmal	O
A.fib	O
on	O
plavix	O
(not	O
coumadin	O
due	O
to	O
history	O
of	O
GI	B-Lower_gastrointestinal_haemorrhage
bleed),	B-Lower_gastrointestinal_haemorrhage
remote	O
hx	O
of	O
breast	O
CA,	O
and	O
recent	O
___	O
Neurology	O
admit	O
in	O
___	O
for	O
amaurosis	B-Visual_impairment
fugax,	B-Visual_impairment
who	O
presents	O
with	O
one	O
day	O
of	O
confusion.	B-Delirium
According	O
to	O
the	O
patient's	O
daughter,	O
this	O
morning	O
at	O
7:30	O
the	O
patient	O
developed	O
a	O
right-sided	O
frontal	O
headache.	O
At	O
the	O
time	O
this	O
was	O
felt	O
to	O
be	O
one	O
of	O
her	O
typical	O
headaches.	O
She	O
was	O
seen	O
by	O
her	O
PCP	O
for	O
an	O
already	O
scheduled	O
appointment,	O
however	O
felt	O
well	O
at	O
that	O
time.	O
On	O
the	O
drive	O
home	O
with	O
her	O
son	O
she	O
began	O
to	O
be	O
confused;	B-Delirium
for	O
example	O
when	O
she	O
arrived	O
home	O
in	O
the	O
driveway	O
she	O
did	O
not	O
realize	O
she	O
was	O
at	O
home	O
and	O
did	O
not	O
get	O
out	O
of	O
the	O
car.	O
Throughout	O
the	O
day	O
she	O
continued	O
to	O
have	O
trouble	O
remembering	O
the	O
events	O
of	O
the	O
day.	O
She	O
then	O
tried	O
to	O
sit	O
down	O
in	O
a	O
chair	O
(on	O
her	O
left	O
side)	O
but	O
missed	O
the	O
chair	O
and	O
fell	B-Falls
to	O
the	O
floor	O
(denies	O
head	O
trauma	O
or	O
LOC).	O
Her	O
daughter	O
brought	O
her	O
into	O
the	O
ED	O
for	O
evaluation.	O
The	O
patient	O
says	O
she	O
feels	O
at	O
baseline	O
and	O
has	O
no	O
complaints.	O
She	O
denies	O
new	O
vision	B-Visual_impairment
or	O
balance	O
problems.	B-Visual_impairment
Her	O
daughter	O
says	O
she's	O
been	O
holding	O
onto	O
objects	O
while	O
walking	O
for	O
the	O
past	O
month,	O
but	O
at	O
baseline	O
walks	B-Independently_mobile
independently.	B-Independently_mobile
In	O
the	O
ED	O
a	O
head	O
CT	O
revealed	O
a	O
hypodensity	O
in	O
the	O
right	O
occipital	O
lobe,	O
new	O
from	O
___.	O
Neurology	O
was	O
consulted	O
for	O
evaluation	O
of	O
a	O
possible	O
new	O
stroke.	O
Of	O
note,	O
she	O
was	O
admitted	O
to	O
the	O
stroke	O
service	O
in	O
___	O
for	O
3	O
episodes	O
of	O
amaurosis	B-Visual_impairment
fugax	B-Visual_impairment
in	O
the	O
right	O
eye.	O
CTA	O
and	O
carotid	O
ultrasound	O
re-demonstrated	O
considerable	O
atherosclerosis	O
in	O
the	O
extra	O
and	O
intracranial	O
vessels	O
(<40%	O
bilaterally)	O
and	O
she	O
was	O
started	O
on	O
a	O
statin	O
and	O
aspirin	O
in	O
addition	O
to	O
her	O
plavix.	O
Her	O
aspirin	O
was	O
discontinued	O
after	O
3	O
months	O
of	O
dual	O
antiplatelet	O
therapy	O
in	O
___.	O
Review	O
of	O
Systems:	O
On	O
neuro	O
ROS,	O
the	O
pt	O
denies	O
loss	B-Visual_impairment
of	B-Visual_impairment
vision,	B-Visual_impairment
new	O
blurred	B-Visual_impairment
vision	B-Visual_impairment
(has	O
baseline	O
poor	B-Visual_impairment
vision	B-Visual_impairment
in	O
left	O
eye),	O
diplopia,	B-Visual_impairment
dysarthria,	O
dysphagia,	O
lightheadedness,	O
vertigo,	O
tinnitus	B-Hearing_impairment
or	O
hearing	B-Hearing_impairment
difficulty.	B-Hearing_impairment
Denies	O
difficulties	O
producing	O
or	O
comprehending	O
speech.	O
Denies	O
focal	O
weakness,	O
numbness,	O
parasthesiae.	O
No	O
bowel	B-Faecal_incontinence
or	O
bladder	B-Urinary_incontinence
incontinence	B-Faecal_incontinence
or	O
retention.	O
Denies	O
difficulty	O
with	O
gait.	O
On	O
general	O
review	O
of	O
systems,	O
the	O
pt	O
denies	O
recent	O
fever	O
or	O
chills.	O
Denies	O
cough,	O
shortness	O
of	O
breath.	O
Denies	O
chest	O
pain	O
or	O
tightness,	O
palpitations.	O
Denies	O
nausea,	O
vomiting,	O
diarrhea,	O
constipation	B-Constipation
or	O
abdominal	O
pain.	O
No	O
recent	O
change	O
in	O
bowel	O
or	O
bladder	O
habits.	O
No	O
dysuria.	O
Denies	O
rash.	O
Past	O
Medical	O
History:	O
-	O
Hypertension	O
-	O
Diastolic	O
congestive	O
heart	O
failure	O
-	O
Paroxysmal	O
atrial	O
fibrillation	O
since	O
___,	O
not	O
on	O
any	O
anticoagulation	O
due	O
to	O
history	O
of	O
GI	B-Upper_gastrointestinal_haemorrhage
bleed	B-Upper_gastrointestinal_haemorrhage
-	O
Diabetes	O
mellitus	O
type	O
2	O
-	O
Breast	O
cancer	O
s/p	O
lumpectomies	O
and	O
XRT	O
-	O
Chronic	O
lymphocytic	O
leukemia,	O
___	O
-	O
IgA	O
autoimmune	O
hemolytic	O
anemia	O
-	O
Hypothyroidism	O
-	O
Diverticulitis	O
-	O
H/O	O
G.I.	B-Upper_gastrointestinal_haemorrhage
bleed	B-Upper_gastrointestinal_haemorrhage
-	O
Amaurosis	B-Visual_impairment
Fugax,	B-Visual_impairment
___	O
Social	O
History:	O
___	O
Family	O
History:	O
Father	O
-	O
CHF,	O
passed	O
away	O
at	O
___,	O
Aortic	O
aneurysm	O
Mother	O
-	O
HTN,	O
intracranial	B-Intracranial_haemorrhage
hemorrhage	B-Intracranial_haemorrhage
Daughter	O
-	O
___	O
CA	O
Physical	O
Exam:	O
ADMISSION	O
EXAM:	O
Vitals:	O
98.6	O
88	O
161/98	O
22	O
97%	O
RA	O
General:	O
Awake,	O
cooperative,	O
NAD.	O
HEENT:	O
NC/AT	O
Neck:	O
Supple.	O
Pulmonary:	O
clear	O
to	O
auscultation	O
bilaterally	O
CV:	O
irregular;	O
no	O
m/r/g	O
ABD:	O
soft,	O
nondistended	O
EXT:	O
2+	O
pitting	O
pedal	O
edema	O
with	O
overlying	O
scale	O
Skin:	O
no	O
rashes	O
or	O
lesions	O
noted.	O
Neurologic:	O
-Mental	O
Status:	O
Alert,	O
oriented	B-Delirium
to	O
BI	O
emergency	O
room	O
and	O
___	O
(chooses	O
___	O
from	O
multiple	O
choice).	O
Language	O
is	O
fluent	O
with	O
intact	O
repetition.	O
Normal	O
prosody.	O
Pt.	O
was	O
able	O
to	O
name	O
high	O
frequency	O
objects	O
but	O
not	O
lower	O
frequency	O
items	O
(pager="band",	O
stethoscope="strap");	O
on	O
stroke	O
cards	O
was	O
unable	B-Visual_impairment
to	B-Visual_impairment
read	B-Visual_impairment
and	O
made	O
multiple	O
paraphasic	O
errors	O
with	O
naming	O
(glove="hand	O
with	O
fingers",	O
cactus="salt	O
and	O
pepper	O
shakers",	O
hammock="swing,"	O
and	O
feather="corn")	O
but	O
this	O
was	O
confounded	O
by	O
not	O
having	O
reading	O
glasses.	O
Speech	O
was	O
not	O
dysarthric.	O
Able	O
to	O
follow	O
both	O
midline	O
and	O
appendicular	O
commands.	O
Inattentive,	O
able	O
to	O
name	O
___	O
forwards	O
but	O
when	O
attempts	O
backwards	O
says	O
"___."	O
Able	O
to	O
register	O
3	O
objects	O
and	O
recall	O
___	O
at	O
5	O
minutes	O
w/clues.	O
There	O
was	O
finger	O
substitution	O
with	O
apraxia	O
testing.	O
Only	O
describes	O
the	O
far	O
right	O
side	O
of	O
the	O
cookie	O
jar	O
picture.	O
-Cranial	O
Nerves:	O
I:	O
Olfaction	O
not	O
tested.	O
II:	O
PERRL	O
3	O
to	O
2mm	O
bilaterally.	O
Left	O
hemifield	B-Visual_impairment
cut,	B-Visual_impairment
tested	O
in	O
each	O
eye	O
w/	O
finger	O
wiggling.	O
III,	O
IV,	O
VI:	O
EOMI	O
without	O
nystagmus.	O
V:	O
Facial	O
sensation	O
intact	O
to	O
light	O
touch	O
in	O
all	O
distributions	O
VII:	O
No	O
facial	O
droop	O
with	O
symmetric	O
upper	O
and	O
lower	O
facial	O
musculature	O
bilaterally	O
VIII:	O
Hearing	B-Hearing_impairment
intact	B-Hearing_impairment
to	O
finger	O
snap	O
bilaterally.	O
IX,	O
X:	O
Palate	O
elevates	O
symmetrically.	O
XI:	O
full	O
strength	O
in	O
trapezii	O
bilaterally.	O
XII:	O
Tongue	O
protrudes	O
in	O
midline	O
with	O
full	O
ROM	O
right	O
and	O
left	O
-Motor:	O
Normal	O
bulk,	O
tone	O
throughout.	O
No	O
pronator	O
drift	O
bilaterally.	O
No	O
tremor	O
noted.	O
Delt	O
Bic	O
Tri	O
WrE	O
FFl	O
FE	O
IO	O
IP	O
Quad	O
Ham	O
TA	O
___	O
L	O
4+	O
___	O
___	O
___	O
5	O
5	O
5	O
5	O
R	O
4+	O
___	O
___	O
___	O
5	O
5	O
5	O
5	O
-DTRs:	O
Bi	O
Tri	O
___	O
Pat	O
Ach	O
L	O
2+	O
2	O
2	O
1	O
0	O
R	O
2+	O
2	O
2	O
1	O
0	O
-	O
Toes	O
were	O
equivocal	O
bilaterally.	O
-Sensory:	O
No	O
deficits	O
to	O
light	O
touch,	O
pinprick	O
throughout.	O
Has	O
position	O
sense	O
loss	O
in	O
toes	O
bilaterally.	O
She	O
has	O
extinction	O
to	O
DDS	O
on	O
left	O
(tactile).	O
Graphesthesia	O
intact.	O
-Coordination:	O
No	O
dysmetria	O
on	O
FNF	O
bilaterally.	O
-Gait:	O
Good	O
initiation.	O
Mildly	O
wide	O
based	O
with	O
feet	O
out-turned.	O
Stride	O
is	O
short	O
and	O
steps	O
are	O
shuffling	O
and	O
tentative.	O
Holds	O
on	O
to	O
objects	O
and	O
people	B-Mobile_with_assistance
for	B-Mobile_with_assistance
assistance.	B-Mobile_with_assistance
DISCHARGE	O
EXAM:	O
****	O
Pertinent	O
Results:	O
ADMISSION	O
LABS:	O
___	O
WBC-11.1*#	O
RBC-4.22	O
Hgb-11.7*	O
Hct-34.1*	O
MCV-81*	O
MCH-27.7	O
MCHC-34.3	O
RDW-15.4	O
Plt	O
___	O
Neuts-75.6*	O
___	O
Monos-3.9	O
Eos-0.6	O
Baso-0.2	O
___	O
PTT-28.4	O
___	O
Glucose-248*	O
UreaN-19	O
Creat-1.0	O
Na-141	O
K-4.5	O
Cl-98	O
HCO3-28	O
AnGap-20	O
ALT-19	O
AST-19	O
LD(LDH)-247	O
AlkPhos-102	O
TotBili-1.0	O
Calcium-8.9	O
Phos-3.4	O
Mg-1.9	O
UA:	O
bland	O
CXR:	O
Cardiomgaly,	O
no	O
consolidation	O
STROKE	O
WORKUP:	O
___	O
Cholest-126	O
Triglyc-91	O
HDL-53	O
CHOL/HD-2.4	O
LDLcalc-55	O
LDLmeas-65	O
%HbA1c-9.1*	O
eAG-214*	O
TSH-2.9	O
IMAGING:	O
CT	O
head	O
___	O
IMPRESSION:	O
New	O
hypodensity	O
in	O
the	O
right	O
posterior	O
temporal	O
lobe	O
since	O
___,	O
concerning	O
for	O
subacute	O
infarction	O
with	O
differentials	O
including	O
vasogenic	O
edema	O
from	O
underlying	O
mass,	O
further	O
evaluation	O
with	O
MRI	O
can	O
be	O
obtained.	O
MRI	B-Intracranial_haemorrhage
head	B-Intracranial_haemorrhage
w/wo,	O
MRA	O
head/neck	O
___	O
IMPRESSION:	O
1.	O
Subacute	O
right	O
posterior	O
temporal/	O
occipital	O
lobe	O
infarct	O
with	O
associated	O
hemorrhage	B-Intracranial_haemorrhage
corresponding	O
with	O
a	O
right	O
posterior	O
cerebral	O
artery	O
distribution.	O
2.	O
No	O
focal	O
vascular	O
occlusion	O
or	O
aneurysm.	O
3.	O
Scattered	O
atherosclerotic	O
vascular	O
disease	O
including	O
intracranial	O
vascular	O
irregularity	O
which	O
appears	O
more	O
prominent	O
when	O
compared	O
to	O
prior	O
CT	O
exam;	O
however,	O
this	O
may	O
be	O
on	O
a	O
technical	O
basis.	O
Brief	O
Hospital	O
Course:	O
___	O
is	O
a	O
___	O
old	O
woman	O
with	O
a	O
history	O
of	O
atrial	O
fibrillation	O
on	O
clopidogrel	O
due	O
to	O
past	O
GI	B-Upper_gastrointestinal_haemorrhage
bleed	B-Upper_gastrointestinal_haemorrhage
while	O
on	O
coumadin,	O
intracranial	O
atherosclerosis,	O
and	O
amaurosis	B-Visual_impairment
fugax	B-Visual_impairment
who	O
presented	O
with	O
headache	O
and	O
confusion.	B-Delirium
On	O
exam	O
she	O
was	O
found	O
to	O
be	O
inattentive,	O
perseverative,	O
and	O
neglecting	O
the	O
left	O
side	O
with	O
a	O
left	O
homonymous	O
hemianopia.	B-Visual_impairment
She	O
was	O
found	O
to	O
have	O
an	O
infarct	O
in	O
the	O
right	O
PCA	O
distribution	O
affecting	O
the	O
occipital	O
and	O
temporal	O
lobes	O
with	O
hemorrhagic	O
transfomation.	O
Stroke	O
workup	O
demonstrated	O
persistent	O
intracranial	O
atherosclerosis;	O
her	O
LDL	O
was	O
65	O
on	O
atorvastatin	O
80	O
mg.	O
She	O
had	O
persistent	O
atrial	O
fibrillation;	O
echocardiogram	O
was	O
not	O
obtained	O
as	O
it	O
would	O
not	O
change	O
her	O
management.	O
Overall	O
her	O
stroke	O
was	O
thought	O
to	O
be	O
secondary	O
to	O
large	O
vessel	O
cardioembolus	O
from	O
her	O
atrial	O
fibrillation,	O
although	O
artery	O
to	O
artery	O
embolus	O
could	O
not	O
be	O
excluded.	O
Given	O
her	O
failure	O
of	O
clopidogrel	O
therapy,	O
a	O
plan	O
was	O
made	O
to	O
start	O
apixaban	O
two	O
weeks	O
after	O
infarct	O
given	O
her	O
hemorrhagic	O
transformation	O
and	O
until	O
that	O
time	O
she	O
was	O
continued	O
on	O
aspirin.	O
She	O
will	O
stop	O
aspirin	O
once	O
she	O
starts	O
apixaban.	O
She	O
was	O
evaluated	O
by	O
physical	O
and	O
occupational	O
therapy	O
who	O
recommended	O
acute	O
rehab.	O
Although	O
she	O
was	O
independent	O
prior	O
to	O
presentation,	O
she	O
may	O
not	O
regain	O
this	O
level	O
of	O
independence	O
given	O
her	O
left-sided	O
field	O
cut	O
and	O
neglect.	O
Her	O
A1c	O
was	O
also	O
elevated	O
at	O
9.1%	O
and	O
___	O
was	O
consulted	O
for	O
management	O
of	O
her	O
diabetes.	O
Given	O
her	O
age	O
and	O
comorbidities,	O
goal	O
A1c	O
of	O
___	O
was	O
most	O
appropriate.	O
She	O
was	O
transitioned	O
from	O
glyburide	O
to	O
glipizide	O
on	O
discharge.	O
Her	O
blood	O
pressure	O
medications	O
were	O
halved	O
on	O
admission	O
for	O
permissive	O
hypertension	O
and	O
were	O
gradually	O
reintroduced	O
to	O
maintain	O
SBP	O
<	O
160	O
given	O
hemorrhagic	O
transformation.	O
Her	O
torsemide	O
had	O
been	O
held	O
on	O
admission.	O
=============================================	O
AHA/ASA	O
Core	O
Measures	O
for	O
Ischemic	O
Stroke	O
and	O
Transient	O
Ischemic	O
Attack	O
1.	O
Dysphagia	O
screening	O
before	O
any	O
PO	O
intake?	O
(x)	O
Yes,	O
confirmed	O
done	O
-	O
()	O
Not	O
confirmed	O
	O
()	O
No	O
2.	O
DVT	O
Prophylaxis	O
administered?	O
(x)	O
Yes	O
-	O
()	O
No	O
3.	O
Antithrombotic	O
therapy	O
administered	O
by	O
end	O
of	O
hospital	O
day	O
2?	O
(x)	O
Yes	O
-	O
()	O
No	O
4.	O
LDL	O
documented?	O
(x)	O
Yes	O
(LDL	O
=	O
65)	O
-	O
()	O
No	O
5.	O
Intensive	O
statin	O
therapy	O
administered?	O
(simvastatin	O
80mg,	O
simvastatin	O
80mg/ezetemibe	O
10mg,	O
atorvastatin	O
40mg	O
or	O
80	O
mg,	O
rosuvastatin	O
20mg	O
or	O
40mg,	O
for	O
LDL	O
>	O
100)	O
(x)	O
Yes	O
-	O
()	O
No	O
[if	O
LDL	O
>100,	O
reason	O
not	O
given:	O
]	O
6.	O
Smoking	O
cessation	O
counseling	O
given?	O
()	O
Yes	O
-	O
(x)	O
No	O
[reason	O
(x)	O
non-smoker	O
-	O
()	O
unable	O
to	O
participate]	O
7.	O
Stroke	O
education	O
(personal	O
modifiable	O
risk	O
factors,	O
how	O
to	O
activate	O
EMS	O
for	O
stroke,	O
stroke	O
warning	O
signs	O
and	O
symptoms,	O
prescribed	O
medications,	O
need	O
for	O
followup)	O
given	O
(verbally	O
or	O
written)?	O
(x)	O
Yes	O
-	O
()	O
No	O
8.	O
Assessment	O
for	O
rehabilitation	O
or	O
rehab	O
services	O
considered?	O
(x)	O
Yes	O
-	O
()	O
No	O
9.	O
Discharged	O
on	O
statin	O
therapy?	O
(x)	O
Yes	O
-	O
()	O
No	O
[if	O
LDL	O
>100,	O
reason	O
not	O
given:	O
]	O
10.	O
Discharged	O
on	O
antithrombotic	O
therapy?	O
(x)	O
Yes	O
[Type:	O
(x)	O
Antiplatelet	O
-	O
()	O
Anticoagulation]	O
-	O
()	O
No	O
11.	O
Discharged	O
on	O
oral	O
anticoagulation	O
for	O
patients	O
with	O
atrial	O
fibrillation/flutter?	O
()	O
Yes	O
-	O
(x)	O
No	O
-	O
()	O
N/A	O
[Plan	O
to	O
start	O
in	O
2	O
weeks	O
given	O
hemorrhagic	O
transformation]	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
2.	O
Clopidogrel	O
75	O
mg	O
PO	O
DAILY	O
3.	O
Diltiazem	O
Extended-Release	O
180	O
mg	O
PO	O
DAILY	O
4.	O
GlyBURIDE	O
0.625	O
mg	O
PO	O
DAILY	O
5.	O
Levothyroxine	O
Sodium	O
100	O
mcg	O
PO	O
DAILY	O
6.	O
Metoprolol	O
Succinate	O
XL	O
100	O
mg	O
PO	O
DAILY	O
7.	O
Torsemide	O
40	O
mg	O
PO	O
DAILY	O
8.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
9.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
Discharge	O
Medications:	O
1.	O
Diltiazem	O
Extended-Release	O
180	O
mg	O
PO	O
DAILY	O
2.	O
Levothyroxine	O
Sodium	O
100	O
mcg	O
PO	O
DAILY	O
3.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
4.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
5.	O
Metoprolol	O
Succinate	O
XL	O
100	O
mg	O
PO	O
DAILY	O
6.	O
GlipiZIDE	O
5	O
mg	O
PO	O
DAILY	O
7.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
STOP	O
THIS	O
MEDICATION	O
WHEN	O
YOU	O
START	O
APIXABAN	O
8.	O
Atorvastatin	O
40	O
mg	O
PO	O
QPM	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Right	O
posterior	O
temporoccipital	B-Intracranial_haemorrhage
lobe	O
infarct	O
with	O
hemorrhagic	B-Intracranial_haemorrhage
conversion	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Confused	B-Delirium
and	O
inattentive.	O
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Dependent.	B-Mobile_with_assistance
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
because	O
of	O
visual	B-Visual_impairment
difficulties	B-Visual_impairment
and	O
confusion	B-Delirium
you	O
experienced	O
on	O
___.	O
We	O
found	O
a	O
moderate-sized	O
right	O
sided	O
stroke	O
that	O
explained	O
your	O
symptoms.	O
It	O
was	O
felt	O
the	O
stroke	O
was	O
a	O
result	O
of	O
a	O
complication	O
of	O
paroxysmal	O
atrial	O
fibrillation.	O
You	O
were	O
started	O
on	O
a	O
medication	O
called	O
aspirin	O
to	O
thin	O
your	O
blood.	O
In	O
two	O
weeks,	O
your	O
PCP	O
should	O
follow	O
up	O
with	O
a	O
new	O
medication,	O
Apixaban,	O
to	O
help	O
avoid	O
stroke	O
recurrence.	O
When	O
you	O
start	O
this	O
new	O
medication,	O
you	O
should	O
stop	O
aspirin.	O
You	O
have	O
been	O
switched	O
from	O
glyburide	O
to	O
glipizide	O
for	O
your	O
diabetes.	O
We	O
wish	O
you	O
the	O
best	O
in	O
your	O
recovery.	O
Please	O
do	O
not	O
hesitate	O
to	O
contact	O
us	O
with	O
any	O
questions	O
or	O
concerns.	O
Sincerely,	O
Your	O
___	O
Neurology	O
Team	O
Followup	O
Instructions:	O
___	O

